Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044)
dc.contributor.author | Bjorner, Jakob B. | |
dc.contributor.author | Gandek, Barbara | |
dc.contributor.author | Cole, Jason | |
dc.contributor.author | Kosinski, Mark | |
dc.contributor.author | Wallenstein, Gene | |
dc.contributor.author | Anatchkova, Milena | |
dc.contributor.author | Ware, John E. Jr. | |
dc.date | 2022-08-11T08:10:41.000 | |
dc.date.accessioned | 2022-08-23T17:16:46Z | |
dc.date.available | 2022-08-23T17:16:46Z | |
dc.date.issued | 2006-12-01 | |
dc.date.submitted | 2010-06-22 | |
dc.identifier.citation | Bjorner, J. B., Gandek B., Cole, J. C., Kosinski, M., Wallenstein, G. V., Anatchkova, M., and Ware J.E., Jr. Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044). 2006. | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/47475 | |
dc.language.iso | en_US | |
dc.subject | Outcome Assessment (Health Care) | |
dc.subject | Product Labeling | |
dc.subject | Research | |
dc.subject | Health Care Sector | |
dc.subject | Biostatistics | |
dc.subject | Epidemiology | |
dc.subject | Health Services Research | |
dc.title | Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044) | |
dc.type | Response or Comment | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1610&context=qhs_pp&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/qhs_pp/611 | |
dc.identifier.contextkey | 1367207 | |
refterms.dateFOA | 2022-08-23T17:16:47Z | |
dc.identifier.submissionpath | qhs_pp/611 | |
dc.contributor.department | Department of Quantitative Health Sciences |